See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Presenter: Yoshinobu Onuma

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

Presentation TCT 2012

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

Presenter: Giulio Stefanini

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

Abluminus (Envision Scientific) Program Update

Presenter: Sameer Dani

October 23, 2012

Presentation TCT 2012

TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes

Presenter: Bishav Garg

October 23, 2012

Presentation TCT 2012

Case 1: During a TAVR

Presenter: Susheel Kodali

October 23, 2012

Presentation TCT 2012

TCT-89. Timing, Predictive Factors and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Luis Nombela-Franco

October 23, 2012

Presentation TCT 2012

Potential Role for Pan-Vascular Imaging: Insights from the HRP Project

Presenter: Valentin Fuster

October 23, 2012

Advertisement

Slides

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Abluminus (Envision Scientific) Program Update

TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes

Case 1: During a TAVR

TCT-89. Timing, Predictive Factors and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation

Potential Role for Pan-Vascular Imaging: Insights from the HRP Project

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content